| LncRNA |
Compound |
Cancer |
P-value |
Effect |
| ENSG00000229582.2 |
Ponatinib |
Bladder urothelial carcinoma |
0.037102352 |
Resistant |
| ENSG00000229582.2 |
Ponatinib |
Brain lower grade glioma |
0.01039401 |
Resistant |
| ENSG00000229582.2 |
Ponatinib |
Pancreatic adenocarcinoma |
0.001384301 |
Resistant |
| ENSG00000229582.2 |
Ponatinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.007217623 |
Sensitive |
